Table 1 Clinicopathological characteristics
From: Outcomes of surgical resection for gastric cancer liver metastases: a retrospective analysis
Variables | |
|---|---|
Sex | |
Male | 13 |
Female | 7 |
Age (years)* | 73.5 (53–89) |
Histological type | |
Well | 3 |
Mod | 11 |
Poor | 3 |
Muc | 3 |
Size of primary tumor (cm)* | 4.5 (2.0–9.0) |
Type of gastrectomy | |
Total gastrectomy | 8 |
Distal gastrectomy | 11 |
Proximal gastrectomy | 1 |
Serosal invasion | |
Present | 4 |
Absent | 16 |
Lymph node metastasis | |
N0 | 3 |
N1 (1, 2) | 5 |
N2 (3–6) | 8 |
N3 (7 ≤) | 4 |
Lymphatic invasion | |
ly0 | 6 |
ly1 | 6 |
ly2 | 5 |
ly3 | 3 |
Venous invasion | |
v0 | 7 |
v1 | 3 |
v2 | 6 |
v3 | 4 |
Number of hepatic tumors* | 1.0 (1–22) |
Maximum size of the metastatic tumor (cm)* | 2.5 (0.8–7.5) |
Time of hepatectomy | |
Synchronous | 11 |
Metachronous | 9 |
Repeat hepatectomy | |
Once | 15 |
Repeat | 5 |
Postoperative chemotherapy (cycle)* | 4.0 (0–27) |
CEA (ng/mL)* | 3.5 (0.8–2230) |
CA19-9 (U/mL)* | 13.3 (0.1–236.2) |
AFP | |
Positive | 4 |
Negative | 16 |